Release of tumor necrosis factor, interleukin-2, and gamma-interferon in serum after injection of OKT3 monoclonal antibody in kidney transplant recipients
about
Infliximab-Related Infusion Reactions: Systematic ReviewImmunotherapy in autoimmune type 1 diabetesTen years of Orthoclone OKT3 (muromonab-CD3): a reviewRapid regulatory T-cell response prevents cytokine storm in CD28 superagonist treated mice.Current status of renal transplantation.TU-100 (Daikenchuto) and ginger ameliorate anti-CD3 antibody induced T cell-mediated murine enteritis: microbe-independent effects involving Akt and NF-κB suppressionPharmacology and safety assessment of humanized monoclonal antibodies for therapeutic use.Lethal effect of CD3-specific antibody in mice deficient in TGF-beta1 by uncontrolled flu-like syndrome.Characterization of a new mouse model for peripheral T cell lymphoma in humans.Overview on the use of therapeutic antibodies in drug discovery.In vivo effects of IgA and IgG2a anti-CD3 isotype switch variantsEvaluation of sequential serum interleukin-6 levels in liver allograft recipientsAnti-CD3 therapy promotes tolerance by selectively depleting pathogenic cells while preserving regulatory T cells.Preclinical screening for acute toxicity of therapeutic monoclonal antibodies in a hu-SCID model.New immunosuppressive approaches: oral administration of CD3-specific antibody to treat autoimmunityModulation of the human T cell response by a novel non-mitogenic anti-CD3 antibodyPhase I trial of a humanized, Fc receptor nonbinding anti-CD3 antibody, hu12F6mu in patients receiving renal allograftsMonoclonal antibodies in renal transplantation: a review.Antibodies in the prevention of renal allograft rejection.The clinical application of monoclonal antibody therapies in renal transplantation.Regulation of endothelial VCAM-1 expression in murine cardiac grafts. Roles for TNF and IL4TGN1412 Induces Lymphopenia and Human Cytokine Release in a Humanized Mouse ModelTumor necrosis factor production during human renal allograft rejection is associated with depression of plasma protein C and free protein S levels and decreased intragraft thrombomodulin expression.Detection of plasma tumor necrosis factor, interleukins 6, and 8 during the Jarisch-Herxheimer Reaction of relapsing feverResetting the functional capacity of regulatory T cells: a novel immunotherapeutic strategy to promote immune tolerance.Differential depletion of total T cells and regulatory T cells and prolonged allotransplant survival in CD3Ɛ humanized mice treated with polyclonal anti human thymocyte globulin.Targeting the TCR: T-cell receptor and peptide-specific tolerance-based strategies for restoring self-tolerance in CNS autoimmune disease.T cell targeted immunotherapy for autoimmune disease.CD3-specific antibodies as promising tools to aim at immune tolerance in the clinic.Critical care perspective on immunotherapy in lung transplantation.Emerging drugs in lung transplantation.Induction of mucosal tolerance in SLE: a sniff or a sip away from ameliorating lupus?Cytokines in clinical and experimental transplantation.Teplizumab therapy for type 1 diabetes.Antibody immunosuppressive therapy in solid-organ transplant: Part I.Immunomodulatory therapy to preserve pancreatic β-cell function in type 1 diabetes.In vitro cytokine release assays: reducing the risk of adverse events in man.CD3 monoclonal antibodies: a first step towards operational immune tolerance in the clinic.Update on procalcitonin measurements.Reestablishing T Cell Tolerance by Antibody-Based Therapy in Type 1 Diabetes.
P2860
Q27013835-69D7F3B6-E13F-4B71-B26A-98682019E0DAQ27025619-8271F2E6-B849-43AB-8A39-9636012D307CQ28241114-EC6D2C1C-C3EE-4202-9867-AEF3378B15ABQ33413095-A710B85B-2E6F-42BF-81E1-890B87E1D609Q33558294-257FD3BD-7E67-476C-99A0-393B2DE76415Q33654829-F30DC506-74CB-4C2F-B1C9-3118ABF67304Q33657568-3B38FD3C-1DE1-49B6-B969-E6CB6DC06844Q33743988-CB917165-E6B9-46B1-ACFA-CE554958FA18Q34097906-546C2722-4A35-495B-80C9-48E9716C6484Q34147273-AA249EB7-314F-46F7-BC35-461FFBBB804DQ34151703-DD615D32-7CAB-48E0-9620-1B87D3E37040Q34498275-87C7E94B-574F-4A25-9AC5-70D26705D362Q34630923-CA7E0E26-1D0F-4706-AA7D-56602BAC0DF4Q34803897-5AF3CE73-BB7B-42B5-8CC9-D6ABC3052E74Q34831889-9099EA30-5939-4C88-AF89-23ED4E489DADQ35142083-5D0FA82C-6184-4D14-884E-6622C75A3625Q35232365-2855A854-4F7B-4500-A5F3-4A84CF2A65FFQ35451349-C01D9399-3D62-476C-8000-D55ECD2ECEE7Q35681527-73729006-8C7F-475D-85A5-FEA5B960922EQ35779272-7CFCBB3D-7DC4-4B0A-9095-71E0ECE71EF2Q35795001-0AF28332-FA99-4C29-99F4-13FBB72AEA47Q35950889-F4DA0A0B-846B-4715-A38A-253EB9A4B0C7Q36230830-0D63F6FD-437D-4633-9AAF-4CFA342DFD7EQ36231303-5A0027B0-D103-4FF9-9387-7B1A5DA3CC44Q36269628-F7D17756-3ED9-4269-BEB2-E65200277373Q36296614-BAE4EBF6-1780-4004-AEBC-2A29863CF9B1Q36327367-2A4D6F33-C733-472C-B6AA-7CE188B1F1D2Q36359571-B9C1A5BF-0A7C-4571-BDAD-49B8895F7158Q36526356-32B33967-BBD2-4FE8-BA90-590F2B739D6BQ36649380-21036D55-7C53-4436-A159-90DC34CAF292Q36758582-33E3CB2B-22C5-47D5-8885-372A838F5A44Q37120570-37E4A8E0-AB5A-4FF5-AF53-4C328E1DA6F4Q37162174-D41C32A6-617E-4988-8C55-BBC21CC79851Q37679927-16E13509-CBC6-4EB7-9B1B-190E7DC5829AQ37691180-00864A2A-4F24-41BF-BB97-7A8352B1528FQ37883029-90BD8FAF-2FE8-4328-84B4-DA22A0AD432AQ37963914-61D78F1E-396C-4A46-9C60-080C15B1E956Q38117284-D4474943-6115-4634-803D-E731247379DAQ38225139-F003970F-C1FE-44A6-8AEB-D2110A1694FFQ38384138-5780296B-7847-4532-9E8D-159F123F9B90
P2860
Release of tumor necrosis factor, interleukin-2, and gamma-interferon in serum after injection of OKT3 monoclonal antibody in kidney transplant recipients
description
1989 nî lūn-bûn
@nan
1989 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1989 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
name
Release of tumor necrosis fact ...... n kidney transplant recipients
@ast
Release of tumor necrosis fact ...... n kidney transplant recipients
@en
Release of tumor necrosis fact ...... n kidney transplant recipients
@nl
type
label
Release of tumor necrosis fact ...... n kidney transplant recipients
@ast
Release of tumor necrosis fact ...... n kidney transplant recipients
@en
Release of tumor necrosis fact ...... n kidney transplant recipients
@nl
prefLabel
Release of tumor necrosis fact ...... n kidney transplant recipients
@ast
Release of tumor necrosis fact ...... n kidney transplant recipients
@en
Release of tumor necrosis fact ...... n kidney transplant recipients
@nl
P2093
P1433
P1476
Release of tumor necrosis fact ...... n kidney transplant recipients
@en
P2093
A Crusiaux
C Toussaint
L Schandene
P Kinnaert
P Vereerstraeten
P356
10.1097/00007890-198904000-00008
P407
P577
1989-04-01T00:00:00Z